It was also reported that SOX2 potentiates an immunosuppressive microenvironment and promotes HNSCC growth in vivo by inhibiting type 1 IFN signaling.[24] Moreover, SOX2+ tumor cells have been identified as CSCs and progenitor cells in SCC. This evidence concerns the gene SOX2 and head and neck squamous cell carcinoma.